Companies: 10,795·Total market cap: $144.5T
BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical Inc.

BMRNNASDAQHealthcare● Active
$56.42
$-0.35(-0.62%)
Market Cap$10.9B
P/E Ratio—
52W High$66.28
52W Low$49.26
SEC Filings

BioMarin Pharmaceutical Inc. (BMRN) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001048477 · BMRN · NASDAQ · as of Jun 8, 2026

Filing snapshot

1,000+
Total Filings
4
Latest Form
2026-06-04
Most Recent
1999
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001048477 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2026-02-26
Fiscal Year End
Feb 26, 2026
Accession No.
0001048477-26-000004
Primary Document
bmrn-20251231.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001048477 · Accession 0001048477-26-000004

Latest Key Filings

10-QQuarterly Report
10-Q
2026-05-05
View 10-Q on SEC
8-KCurrent Report
8-K
2026-06-04Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
8-KCurrent Report
8-K
2026-06-04
View
10-QQuarterly Report
10-Q
2026-05-05
View
8-KCurrent Report
8-K
2026-05-04
View
SCHEDULE 13GSCHEDULE 13G
SCHEDULE 13G
2026-04-29
View
8-KCurrent Report
8-K
2026-04-27
View
8-KCurrent Report
8-K
2026-04-23
View
ARSARS
ANNUAL REPORT TO SECURITY HOLDERS
2026-04-21
View
DEFA14AProxy Statement (Additional)
DEFA14A
2026-04-21
View
DEF 14AProxy Statement
DEF 14A
2026-04-21
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-03-26
View
8-KCurrent Report
8-K
2026-03-16
View
10-KAnnual Report
10-K
2026-02-26
View
8-KCurrent Report
8-K
2026-02-23
View
55
FORM 5
2026-02-13
View
55
FORM 5
2026-02-13
View
Showing 1–15 of 313 filingsForm 4 / 144 hidden· 1000 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001048477  |  Exchange: NASDAQ · Healthcare

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) has submitted 1,000+ documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 1999. As a Healthcare sector company with CIK 0001048477, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is BioMarin Pharmaceutical Inc.'s most comprehensive regulatory disclosure. The most recent BioMarin Pharmaceutical Inc. 10-K was filed on 2026-02-26 for fiscal year ending 2026. Historical BMRN 10-K annual reports are available from 2016 through 2026.

Investors researching BioMarin Pharmaceutical Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-08
Related Companies SEC Filings — Healthcare
RVMD SEC Filings →MRNA SEC Filings →EXEL SEC Filings →BBIO SEC Filings →ALGN SEC Filings →MDGL SEC Filings →HALO SEC Filings →TECH SEC Filings →
→ BMRN Financials→ BMRN Earnings→ BMRN Insider Trades

Frequently Asked Questions

BMRN SEC Filings · 8 questions

BioMarin Pharmaceutical Inc. (BMRN) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 1,000+ filings and access original documents at no cost. BioMarin Pharmaceutical Inc.'s CIK is 0001048477.

BMRN SEC filingsBioMarin Pharmaceutical Inc. SEC documentsfind BMRN 10-K